Cointime

Oculogica

company

About

Oculogica specializes in the fields of neuro-diagnostics, brain injury, TBI, concussion, and eye tracking.

  • 1 - 10

Highlights

Total Funding Amount
$10.17M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Series A
Last Funding Money Raised
$8.17M
Industries
Health Care,Health Diagnostics,Medical,Neuroscience
Founded date
Jan 1, 2013
Number Of Employee
1 - 10
Operating Status
Active

Oculogica is a medical device manufacturing company that specializes in the fields of neuro-diagnostics, brain injury, TBI, concussion, and eye-tracking. The company's EyeBOX device is the only baseline-free test authorized by the FDA as an aid in the diagnosis of concussion, also known as mild traumatic brain injury (mTBI). It requires no baseline data nor individual calibration, and therefore results cannot be influenced by patient will.

Oculogica was established in 2013 and is based in New York, NY, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$10.17M
Oculogica has raised a total of $10.17M in funding over 2 rounds. Their latest funding was raised on May 18, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 18, 2021 Grant $2M 1 U.S. Army Medical Research & Development Command — Detail
Jul 17, 2019 Series A $8.17M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Oculogica is funded by 2 investors. U.S. Army Medical Research & Development Command and Colle Capital Partners are the most recent investors.
Investor Name Lead Investor Funding Round
U.S. Army Medical Research & Development Command Yes Grant
Colle Capital Partners — Series A
Cointime
Content
Company